Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pet Valu Holdings Ltd T.PET

Alternate Symbol(s):  PTVLF

Pet Valu Holdings Ltd. is a Canadian specialty retailer of pet food and pet-related supplies. The Company has over 800 corporate-owned or franchised locations across the country. Through its neighborhood stores and digital platform, the Company offers more than 9,000 competitively priced products, including an assortment of premium, super premium and holistic brands. Its family of stores consists of Pet Valu, Bosley’s by Pet Valu, Total Pet and Tisol Pet Nutrition & Supply. Its product categories include puppy essentials, dog food, dog treats, dog toys, dog collars, leashes & harnesses, dog carriers & travel, kitten essentials, cat food, cat litter & litter boxes, cat bowls & feeding, small pet food, treats & hay and aquariums, kits & tanks. Its brands include Performatrin Ultra, ACANA, Royal Canin, ORIJEN, Go! Solutions, Performatrin Prime, Hill's Science Diet, Big Country Raw, Open Farm and Stella & Chewy’s, Purina Proplan, Purina Pro Plan, and Weruva.


TSX:PET - Post by User

Post by retiredcfon Mar 06, 2024 9:27am
73 Views
Post# 35917708

CIBC Report

CIBC Report
EQUITY RESEARCH
March 5, 2024 Earnings Update
PET VALU HOLDINGS LTD.
The Dog Days Of A Growth Story

Our Conclusion
Though Pet Valu closed 2023 with strong results, the 2024 outlook calls for
another year of muted EPS growth, this time weighted by slower same-store
sales (SSS) growth, accelerated price investments, and higher D&A and I/E.
This will likely defer upside, though we remain confident in PET’s ability to
outpace the industry. Our 2024 EPS estimate falls to $1.60 and we introduce
our 2025 estimate of $1.86, implying mid-teens growth. Improving FCF is
supportive and our price target moves to $34 based on 18x 2025E EPS. Our
rating stays Outperformer.
 
Key Points
Another Year Of Muted EPS Growth: Guidance for 2024 includes 2%-5%
SSS growth (CIBCe 3.3%) and revenue growth of 5%-8% (CIBCe 6.5%),
driven by 40-50 new stores (CIBCe 43) and ~$20MM-25MM of incremental
shipments to Chico. However, there are two key factors that should negate
this growth and keep EPS approximately flat. First, the company is investing
in its value proposition to hold relevance. Second, we expect higher D&A and
I/E will clip ~20 cents more of EPS this year vs. last year.
 
Consumer Remains An Impediment: We remain cautious in our view of
overall consumer health and spending, and do not expect the pressure from
higher interest rates on household budgets to abate anytime soon. On the
positive, the pet industry has proven resilient in past periods of contraction
and PET is not seeing substantial evidence of trade-down. We view the price
investments as a prudent step to mitigate risk of channel shift given the
macro backdrop. However, PET will need to maintain discipline and take
specific measures to ensure leverage materializes as conditions improve.
 
Maintain Conviction In Medium-term Opportunity: The prospect of two
years without any EPS growth is disappointing, but we believe PET will
emerge from this period of investment a stronger business. PET will launch a
new digital platform in Q2/24 that will vastly improve the omnichannel
experience and enable better engagement. The supply chain is already in
much better shape than 18 months ago and will likely be incrementally better
again 18 months from now. We believe these investments will drive a re-
ignition of market share gains (PET held at 18% in 2023, still #1 spot),
supported by further store openings. Importantly, franchisee economics were
also updated in the annual disclosures and remain excellent.
 
Valuation Supported By Free Cash Flow Ramp-up: At an 18.7x 2024E
P/E, PET shares do not jump out as compelling given the muted EPS
growth. However, this moderates to 16x based on 2025, which we view as
attractive for a business with a mid-teens EPS growth formula. PET needs to
execute and re-build some credibility to begin to get more credit, but in the
meantime, capex is moderating, inventory investments are done, and PET is
largely done de-leveraging. FCF should more than double in 2024 and put
PET in a position to act on its NCIB in H2/24, accelerating in 2025. Though
some patience is needed, we believe investors will be rewarded in time.

<< Previous
Bullboard Posts
Next >>